BackGreenwich LifeSciences Overview

Greenwich LifeSciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GLSI.

Quarterly EBIT

-$5.73M
74.44% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$21.89M
30.98% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)